A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DMPS / 2,3-dimercapto-1-propanesulfonic acid

[Related PubMed/MEDLINE]
Total Number of Papers: 251
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DMPS  (>> Co-occurring Abbreviation)
Long Form:   2,3-dimercapto-1-propanesulfonic acid
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator. CP, DPA, SWI, WD
2020 Arsenic Toxicity: Molecular Targets and Therapeutic Agents. DHLA, DMSA
2020 Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease. DPA, GAS, WD
2020 Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite. ---
2019 A Review on Coordination Properties of Thiol-Containing Chelating Agents Towards Mercury, Cadmium, and Lead. alpha-LA, Cd, DMSA
2019 Fixed drug eruption due To 2,3-dimercapto-1-propanesulfonic acid (DMPS) treatment for mercury poisoning: a rare adverse effect. FDE
2019 Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology. alpha-LA, DHLA, DMSA, ROS
2019 Stepwise Reduction Approach Reveals Mercury Competitive Binding and Exchange Reactions within Natural Organic Matter and Mixed Organic Ligands. AA, Cys, DOM, Pen
2018 A case report: Co-occurrence of Wilson disease and oculocutaneous albinism in a Chinese patient. OCA, WD
10  2017 Dimercapto-1-propanesulfonic acid (DMPS) induces metaphase II mouse oocyte deterioration. CH, MT
11  2017 Is Chelation Therapy Efficient for the Treatment of Intravenous Metallic Mercury Intoxication? ---
12  2017 Metal chelators and neurotoxicity: lead, mercury, and arsenic. DMSA
13  2017 Survival without peripheral neuropathy after massive acute arsenic poisoning: Treated by 2,3-dimercaptopropane-1-sulphonate. ---
14  2017 The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments. BUN, DMSA
15  2017 [Healing of Amyotrophic Lateral Sclerosis: A Case Report]. ALS, EMG
16  2016 A review of pitfalls and progress in chelation treatment of metal poisonings. CaEDTA, DDC, DMSA, DTPA
17  2016 Clinical efficacy of combined sodium dimercaptopropanesulfonate and zinc treatment in neurological Wilson's disease with D-penicillamine treatment failure. DPA, WD
18  2016 Effects of Zinc Chelators on Aflatoxin Production in Aspergillus parasiticus. ---
19  2016 Nano drug delivery systems: a new paradigm for treating metal toxicity. DMSA
20  2015 Chelation therapy in intoxications with mercury, lead and copper. DMSA
21  2015 Dimercaptopropane Sulfonate Chelation Affects In Vivo Hg and MeHg Distribution in Tissues and Urine of Prairie Voles (Microtus ochrogaster). ---
22  2015 Identification and Characterization of EDTA Test Strip Interfering Substances Using a Digital Color Detector. ALA, DEF, DMSA, EDTA, EGTA, Pen
23  2015 Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China. UWDRS, WD
24  2014 Current approaches of the management of mercury poisoning: need of the hour. BAL
25  2014 Inhibitory mechanism of dimercaptopropanesulfonic acid (DMPS) in the cellular biomethylation of arsenic. ROS
26  2014 Structural characterization of Cd⁺ complexes in solution with DMSA and DMPS. DMSA
27  2013 Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease. PCA, WD
28  2013 Plasma and urine dimercaptopropanesulfonate concentrations after dermal application of transdermal DMPS (TD-DMPS). TD-DMPS, TD-DMPS
29  2013 Recommendations for provoked challenge urine testing. DMSA, EDTA
30  2013 The association between amalgam dental surfaces and urinary mercury levels in a sample of Albertans, a prevalence study. DMSA
31  2012 Development of metal-chelating inhibitors for the Class II fructose 1,6-bisphosphate (FBP) aldolase. DPA, FBP
32  2012 Effects of co-administration of dietary sodium arsenate and 2,3-dimercaptopropane-1-sulfonic acid (DMPS) on the rat bladder epithelium. 8OHdG, BrdU, SEM
33  2012 In vitro assessment of chelating agents with regard to their abstraction efficiency of Cd(2+) bound to plasma proteins. DMSA, DTPA, NAC
34  2012 Influence of glutathione chemical effectors in the response of maize to arsenic exposure. DMS
35  2012 Lessons learned from a fatal case of mercury intoxication. DMSA
36  2012 Severe cobalt intoxication following hip replacement revision: clinical features and outcome. ---
37  2012 Study of disulfide reduction and alkyl chloroformate derivatization of plasma sulfur amino acids using gas chromatography-mass spectrometry. DTT, GC-MS, MESNA, TCA, THP
38  2011 Differences in the substrate binding regions of renal organic anion transporters 1 (OAT1) and 3 (OAT3). OAT1
39  2011 Vicinal thiols are required for activation of the alphaIIbbeta3 platelet integrin. PAO, PCMBS
40  2011 [Prognosis and treatment of fulminant Wilson's disease]. FWD, PE, PTA
41  2011 [The clinical analysis of mercury poisoning in 92 cases]. ---
42  2011 [Values of serum copper and serum free copper in the diagnosis and monitoring of Wilson's disease and its carriers]. WD
43  2010 Care of patients who are worried about mercury poisoning from dental fillings. ---
44  2010 Increased urinary excretion of carnitine and acylcarnitine by mercuric chloride is reversed by 2,3-dimercapto-1-propanesulfonic acid in rats. AC, FC, TC
45  2010 Organic anion transporter 3 (OAT3) and renal transport of the metal chelator 2,3-dimercapto-1-propanesulfonic acid (DMPS). 6-CF, OAT3
46  2010 Paradoxical effect of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on enhancing antitumor activity of cisplatin in ascites sarcoma 180 cells. DMSA, S180 cells
47  2010 Quantification and identification of mitochondrial proteins containing vicinal dithiols. NEM, PAO, Redox-DIGE
48  2010 Synthesis and structural determination of multidentate 2,3-dithiol-stabilized Au clusters. AFM, DTCs, HSQC, NMR, TGA, XPS
49  2009 Acute mercury intoxication and use of chelating agents. DMSA
50  2009 Binding of Hg2+ with phytochelatins: study by differential pulse voltammetry on rotating Au-disk electrode, electrospray ionization mass-spectrometry, and isothermal titration calorimetry. ESI-MS, ITC
51  2009 Comparison of different medical cases in urinary arsenic speciation by fast HPLC-ICP-MS. AsB
52  2009 Concomitant administration of sodium 2,3-dimercapto-1-propanesulphonate (DMPS) and diphenyl diselenide reduces effectiveness of DMPS in restoring damage induced by mercuric chloride in mice. CAT, GST, LDH, TBARS
53  2009 Effect of DMPS and DMSA on the placental and fetal disposition of methylmercury. DMSA
54  2009 Effects of chelators on mercury, iron, and lead neurotoxicity in cortical culture. DMSA, DPA
55  2009 Minimal-change nephrotic syndrome due to occupational mercury vapor inhalation. ---
56  2009 MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA. DMSA
57  2009 Study of the Hg2+ binding with chelation therapy agents by differential pulse voltammetry on rotating Au-disk electrode and electrospray ionization mass-spectrometry. D-Pen, DMSA, DPV, ESI-MS, MCR-ALS, Pen, Pen
58  2008 Gas chromatographic-mass spectrometric analysis of biomarkers related to folate and cobalamin status in human serum after dimercaptopropanesulfonate reduction and heptafluorobutyl chloroformate derivatization. GC/MS, HFBCF
59  2008 Heavy metal induced oxidative stress & its possible reversal by chelation therapy. BAL, DMSA
60  2008 MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury. Cys, DMSA, Hcy
61  2008 Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid. DMSA, Mrp2
62  2008 Severe acute copper sulphate poisoning: a case report. CSP
63  2008 Severe iatrogenic bismuth poisoning with bismuth iodoform paraffin paste treated with DMPS chelation. BIPP
64  2008 Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. SJS
65  2008 The role of thiol-reducing agents on modulation of glutamate binding induced by heavy metals in platelets. DTT
66  2008 Vanadium detoxification: on the interaction of oxovanadium(IV) and other vanadium species with 2,3-dimercapto-1-propanesulfonate. ---
67  2007 Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation: a review. BAL, DMSA
68  2007 Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents. delta-ALA-D, DTT, NAC
69  2007 DMPS reverts morphologic and mitochondrial damage in OK cells exposed to toxic concentrations of HgCl2. DPPH, OK
70  2007 Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on methylmercury-induced locomotor deficits and cerebellar toxicity in mice. TBARS
71  2007 Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats. ALAD, DMSA, MiADMSA, MT, SOD
72  2007 The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. ALA, DHLA, DMSA, NAC
73  2006 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase lead-induced inhibition of delta-aminolevulinate dehydratase in vitro and ex vivo. delta-ALA-D, DMSA
74  2006 Antioxidants and metallothionein levels in mercury-treated mice. AST, delta-ALA-D, MT, NAC, NPSH, TBARS
75  2006 Dithiol compounds at low concentrations increase arsenite toxicity. DMSA, DTT
76  2006 DMPS and N-acetylcysteine induced renal toxicity in mice exposed to mercury. AST, delta-ALA-D, NAC, NPSH, TBARS
77  2006 Effect of mercuric chloride on urinary excretion of free hydroxyproline. i.p
78  2006 GEA3162, a nitric oxide-releasing agent, activates non-store-operated Ca2+ entry and inhibits store-operated Ca2+ entry pathways in neutrophils through thiol oxidation. CPA, fMLP, NO, TCEP
79  2006 Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review. DMSA
80  2006 Neither DMPS nor DMSA is effective in quantitative elimination of elemental mercury after intentional IV injection. DMSA
81  2006 The role of glutathione on the cytotoxic effects and cellular uptake of diphenylarsinic acid, a degradation product of chemical warfare agents. DPAA, SH
82  2005 Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. DMSA, GPx, GST, MiADMSA, ROS, SOD
83  2005 Effect of mercuric chloride on various hydroxyproline fractions in rat serum. Hyp
84  2005 Efficacy of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and diphenyl diselenide on cadmium induced testicular damage in mice. AST, delta-ALA-D, LDH
85  2005 Efforts to control the errant products of a targeted in vivo generator. 213Bi, 221Fr, 225Ac, DMSA
86  2005 Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats. CVAAS, DMSA
87  2005 Stimulation of intracellular Ca2+ elevation in neutrophils by thiol-oxidizing phenylarsine oxide. 2-APB, DMP, DTT, NAC, NO, PAO, PKC, PMA, ROI, TCEP
88  2005 Supplementing copper at the upper level of the adult dietary recommended intake induces detectable but transient changes in healthy adults. ---
89  2005 [Experimental study on the effects of BSO, GSH, vitamin C and DMPS on the nephrotoxicity induced by mercury]. BSO, i.p, sc, VC
90  2004 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid, and meso-2,3-dimercaptosuccinic acid inhibit delta-aminolevulinate dehydratase from human erythrocytes in vitro. delta-ALA-D, DMSA, DTT
91  2004 Analysis of time-dependent recovery from beryllium toxicity following chelation therapy and antioxidant supplementation. DPA, Se
92  2004 In vitro cytotoxic and genotoxic effects of diphenylarsinic acid, a degradation product of chemical warfare agents. DTT, SH
93  2004 Influence of heavy metals upon the retention and mobilization of polonium-210 in rats. 210Po, MT
94  2004 Interaction of the metal chelator DMPS with OAT1 and OAT3 in intact isolated rabbit renal proximal tubules. RPT
95  2004 Lead-induced oxidative stress and hematological alterations and their response to combined administration of calcium disodium EDTA with a thiol chelator in rats. AChE, ALAD, ALAS, GST, MAO, MiADMSA, ROS, SOD, TBARS
96  2004 Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury. DMSA
97  2003 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase. delta-ALA, delta-ALA-D, DMSA
98  2003 Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity. AD, APOE
99  2003 Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning. DMA, MMA
100  2003 Case report: severe mercuric sulphate poisoning treated with 2,3-dimercaptopropane-1-sulphonate and haemodiafiltration. CVVHDF